Stock Earnings

Question 1

What are Protagenic Therapeutics, Inc.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Eledon Pharmaceuticals Inc has a total asset of $169, Net loss of $-45

Question 2

What are the key financial ratios for PTIXW?

Accepted Answer

Eledon Pharmaceuticals Inc's Current ratio is 5.28, has a Net margin is 0, sales per share of $0.

Question 3

How is Protagenic Therapeutics, Inc.'s revenue broken down by segment or geography?

Accepted Answer

Eledon Pharmaceuticals Inc largest revenue segment is Banking and Related Activities, at a revenue of 79,360,144 in the most earnings release.For geography, United States is the primary market for Eledon Pharmaceuticals Inc, at a revenue of 79,360,144.

Question 4

Is Protagenic Therapeutics, Inc. profitable?

Accepted Answer

no, according to the latest financial statements, Eledon Pharmaceuticals Inc has a net loss of $-45

Question 5

Does Protagenic Therapeutics, Inc. have any liabilities?

Accepted Answer

yes, Eledon Pharmaceuticals Inc has liability of 32

Question 6

How many outstanding shares for Protagenic Therapeutics, Inc.?

Accepted Answer

Eledon Pharmaceuticals Inc has a total outstanding shares of 75.43

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	16	16	18	12	12	13
Research & Development	66	66	51	30	27	23
Operating Expenses	83	83	70	43	39	36
Other Non Operating Income (Expenses)	37	37	34	-73	0	0
Pretax Income	-45	-45	-35	-116	-87	-36
Income Tax Expense	0	0	0	0	0	-2
Net Income	-45	-45	-36	-116	-87	-34
Net Income Growth	-31%	25%	-69%	33%	156%	55%
Shares Outstanding (Diluted)	95.9	81.83	48.54	24.61	14.29	14.82
Shares Change (YoY)	37%	69%	97%	72%	-4%	922%
EPS (Diluted)	-0.47	-0.55	-0.74	-4.73	-6.16	-2.33
EPS Growth	-49%	-25%	-84%	-23%	164%	-85%
Free Cash Flow	-62	-62	-47	-39	-28	-28
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	-36
EBITDA Margin	--	--	--	--	--	0%
D&A For EBITDA	--	--	--	--	--	0
EBIT	-83	-83	-70	-43	-39	-36
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	5.55%

Protagenic Therapeutics, Inc. (PTIXW) Financial

PTIXW Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

PTIXW Income

Follow-Up Questions